As wound care products become more focused on infection control, moisture management, comfort, and reliable performance, the material used for the wound-contact layer has become increasingly important. Antibacterial Spunlace Nonwoven combines the soft, absorbent structure of hydroentangled nonwoven fabric with an antibacterial treatment designed to help control bacterial growth at the dressing interface.
For wound dressing manufacturers, the challenge is not simply to add antibacterial functionality. The fabric must also maintain wet strength, absorb wound exudate, minimize lint, remain comfortable against sensitive tissue, and be compatible with sterilization and downstream converting processes.
Zhejiang Aojia Nonwoven Technology Co., Ltd. develops medical spunlace materials based on hydroentanglement technology and supports customized functional treatments, including antibacterial, hydrophilic, water-repellent, anti-static, anti-aging, flame-retardant, and composite solutions. Its medical series includes spunlace materials designed for wound dressings and other medical applications.
A wound dressing creates a temporary interface between the wound and the external environment. Because wound exudate contains moisture and nutrients, the dressing structure can become a favorable location for microbial growth if contamination is not properly controlled.
Antibacterial spunlace does not replace sterile manufacturing, proper wound cleaning, or clinical infection-control procedures. Instead, its role is to provide an additional material-level function that can help inhibit bacterial proliferation on or within the dressing structure.
This is particularly relevant to wound-contact materials because bacterial contamination can affect dressing performance as well as the wound environment. For manufacturers, antibacterial performance therefore needs to be considered together with absorbency, fluid transfer, wet strength, linting, biocompatibility, and sterilization stability.
The key engineering objective is to achieve controlled antibacterial performance without sacrificing the properties that make spunlace suitable for wound care.
The performance of an antibacterial spunlace fabric starts with the construction of its base nonwoven structure. A typical manufacturing route includes several controlled stages.
The selected fibers are opened, cleaned, blended, carded, and formed into a relatively uniform web. Fiber selection has a direct influence on absorbency, softness, strength, dimensional stability, and surface characteristics.
For wound dressing substrates, a viscose/polyester blend is particularly useful because viscose provides hydrophilicity and softness, while polyester contributes dimensional stability and wet mechanical strength. Aojia's medical-series wound dressing material uses a 70% viscose / 30% polyester platform, with medical fabric specifications generally available in the 40–60 g/m² range.
The prepared fiber web is then processed by high-pressure water jets. The water streams penetrate the web and mechanically entangle the fibers, producing a coherent three-dimensional structure without relying on conventional chemical binders or thermal bonding.
This process is important for medical applications because it can create a soft, textile-like surface while maintaining good structural integrity. The hydroentangled structure also helps reduce loose fiber ends compared with some mechanically needled constructions.
After the base fabric has been formed, antibacterial functionality can be introduced according to the intended application and performance requirements.
Possible approaches include surface treatment or incorporation of an antibacterial component into the fiber system. The selection depends on factors such as target microorganisms, required durability, skin-contact requirements, sterilization method, regulatory requirements, and whether the antibacterial function must remain stable after subsequent converting.
A critical point for manufacturers is that antibacterial activity should be validated on the finished material under the intended test conditions, rather than assuming that the presence of an antibacterial treatment automatically guarantees the required performance.
Aojia specifically lists anti-bacterial treatment among its available customized spunlace processes.
After treatment, the fabric can be dried, wound, slit, laminated, or otherwise converted according to the customer's production requirements.
Quality control should cover more than antibacterial performance. Important parameters include basis weight, width, tensile strength, wet strength, absorbency, surface uniformity, lint generation, dimensional stability, and treatment consistency.
For medical applications, the final material also needs to be evaluated for compatibility with the intended sterilization and finished-device manufacturing process.
Spunlace is attractive for wound dressing applications because several properties can be engineered within the same material platform.
The hydroentangled fiber network can provide a soft and flexible surface suitable for prolonged skin contact. This is particularly valuable when a dressing must conform to curved or moving body areas.
Surface structure can also be customized. A plain structure provides a relatively smooth contact surface, while mesh structures can provide more open pathways for fluid transfer and air circulation.
Fiber composition strongly influences liquid handling.
Viscose is hydrophilic and can rapidly take up wound exudate. However, simply maximizing absorption is not always the correct engineering target. A wound dressing also needs to control where the absorbed fluid goes and how long the wound-contact surface remains appropriately moist.
Mesh or open structures can facilitate transfer of exudate toward a secondary absorbent layer, while a higher basis weight can provide additional material capacity. Therefore, absorbency should be evaluated together with fluid retention, vertical wicking, moisture vapor transmission, and the construction of the complete dressing.
A wound dressing may become saturated during use, making wet strength particularly important.
A fabric with insufficient wet integrity can tear during dressing removal or handling. In contrast, a properly engineered viscose/polyester spunlace structure uses polyester reinforcement to help maintain dimensional and mechanical stability after liquid exposure.
For wound dressing manufacturers, wet tensile strength and burst strength should therefore be treated as key selection criteria rather than relying only on dry tensile strength.
Loose fibers are undesirable in wound-care environments because particles left at the wound interface can compromise product cleanliness and patient safety.
Hydroentanglement mechanically locks fibers into the fabric structure and can produce a low-lint surface when the fiber selection and processing conditions are properly controlled. This makes spunlace attractive for wound-contact layers, surgical materials, and other medical textiles where particle shedding must be minimized.
The antibacterial function should be considered as one component of a multi-functional wound dressing system.
An antibacterial finish is designed to inhibit the growth or proliferation of selected microorganisms on the textile. Depending on the treatment technology, antibacterial activity can be based on different mechanisms, such as interaction with microbial cell membranes or controlled release of active antibacterial components.
The appropriate technology depends on the target organisms and intended medical application. Manufacturers should establish the required antibacterial spectrum and test method before selecting the treatment.
A wound-contact material must balance microbial control with biological compatibility.
An aggressive antimicrobial treatment is not automatically better. Excessive release, unsuitable chemistry, or poor fixation can create additional compatibility or regulatory concerns. The better approach is to define the required antibacterial performance first and then engineer the treatment level, durability, and release behavior around that requirement.
This is why antibacterial performance, cytotoxicity, skin irritation, sensitization, extractables, and sterilization stability should be considered as a connected validation program.
Antibacterial spunlace does not necessarily need to function as the entire dressing.
It can serve as a wound-contact layer combined with an absorbent core, superabsorbent polymer, hydrocolloid, barrier film, or other functional layer. In a multi-layer dressing, the spunlace layer can provide soft contact, controlled fluid transfer, and antibacterial functionality while the underlying absorbent layer manages larger volumes of exudate.
This construction allows manufacturers to optimize each layer for a specific function rather than forcing one material to provide every performance characteristic.
Several variables can change the final performance of an antibacterial spunlace material.
| Factor | Main Influence | Manufacturing Consideration |
|---|---|---|
| Fiber composition | Absorbency, softness, strength | Select viscose/PET ratio according to application |
| Antibacterial treatment | Microbial inhibition | Control treatment type, concentration, distribution, and durability |
| Fabric weight and structure | Fluid capacity and mechanical stability | Select GSM and plain/mesh structure according to dressing design |
| Moisture exposure | Wet strength and bacterial environment | Evaluate performance after saturation or prolonged exposure |
| Processing conditions | Uniformity and consistency | Control hydroentanglement, drying, finishing, and winding parameters |
| Sterilization | Mechanical and antibacterial stability | Validate performance after the intended sterilization cycle |
| Converting | Edge quality and structural integrity | Control tension, slitting, lamination, and die cutting |
The interaction between these factors is often more important than any single specification.
For example, increasing viscose content may improve absorbency but can change wet mechanical behavior. Increasing fabric weight may increase liquid capacity but also change flexibility and breathability. A more open mesh may improve fluid transfer but reduce the material's effective surface coverage.
For this reason, wound dressing development should begin with the requirements of the finished product rather than selecting a fabric based on GSM alone.
Medical dressing manufacturers often require different combinations of absorbency, antibacterial performance, strength, surface structure, and converting characteristics.
Aojia Nonwoven operates two spunlace production lines, including a line dedicated to product development and specialty production. Its customization capabilities include fiber composition, basis weight, surface structure, width, and functional finishing. The company also supports special processes such as antibacterial, hydrophilic, water-repellent, anti-static, anti-aging, anti-ultraviolet, and composite treatments.
For a customized Antibacterial Spunlace Nonwoven project, manufacturers can evaluate the following parameters:
Fiber blend and fiber fineness
Basis weight and roll width
Plain or mesh surface structure
Absorption and fluid-transfer requirements
Wet tensile and burst strength
Antibacterial performance against specified microorganisms
Lint and particle-shedding performance
Skin-contact and biocompatibility requirements
Sterilization compatibility
Lamination or composite construction
Slitting, roll length, and converting requirements
The company's medical spunlace portfolio includes wound dressing substrates as well as materials for face masks and other medical applications. The broader product platform also covers wipes, base cloth, wiping cloth, and cosmetology spunlace materials, allowing medical converters to evaluate related materials within the same manufacturing system.
When sourcing antibacterial spunlace for wound dressings, buyers should avoid evaluating the product only by the words "antibacterial" or "medical grade."
A more useful technical checklist includes:
What antibacterial performance is required?
Define target microorganisms, test method, reduction requirement, and whether testing is required before and after sterilization.
How will the fabric manage exudate?
Check absorbency, wicking, fluid transfer, retention, and compatibility with the absorbent core.
Will the fabric remain intact when wet?
Request wet tensile and other relevant mechanical test data rather than relying exclusively on dry strength.
Is the surface appropriate for direct wound contact?
Evaluate softness, linting, surface uniformity, and the possibility of fiber residue.
Can the material withstand the finished product process?
Sterilization, lamination, coating, adhesive application, die cutting, and packaging can all affect the final material.
Can the supplier customize the fabric?
Custom fiber ratios, GSM, surface structure, antibacterial treatment, and roll dimensions can be important when developing a specialized wound dressing.
